Beijing Science Sun Pharmaceutical Co., Ltd.

¥7.83As of Sun 8 Nov 2026, 12:00 UTC
SZSE:300485Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (9.67%)
Div yield 3.83%
ROE (5.19%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.35
PE TTM —
TSR TTM (36.94%)
Mkt cap ¥3.771B
ROIC (1.80%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥9.02
15.21%
(84.03%)
Hold 7|8|6|11|4
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.09
0.09
0.10
0.11
3.19%
4.84%
13.33%
22.84%
Revenue¥M
224.5
237.4
250.4
250.5
(2.68%)
5.28%
12.37%
14.60%
Peers (US$565.3M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.327
(0.670)
(0.504)
EBIT/Intx
2.563
2.686
2.476
Own earn%
25.19
(63.66)
(48.17)
Sh yield%
45.92
35.35
35.68
Owners
Insiders/Inst%
3.77
83.80
Short interest%
0.51
SBC / revenue%
1.90
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
9–21
$1 testx
—
Incr. ROIC%
5